📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

HOXA9 and ß-catenin safeguard HSC integrity. (2024)

First Author: Mapperley C

Attributed to: Therapeutic targeting of HIF prolyl hydroxylases in acute myeloid leukaemia funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1182/blood.2023023755

PubMed Identifier: 38635250

Publication URI: http://europepmc.org/abstract/MED/38635250

Type: Journal Article/Review

Volume: 143

Parent Publication: Blood

Issue: 16

ISSN: 0006-4971